Request for Project Proposals: Advanced Research and Development of Medical Countermeasures Through Agile and Distributed End-to-End Drug Manufacturing
The Administration for Strategic Preparedness and Response, Industrial Base Management and Supply Chain (APSR IBMSC) is seeking to establish advanced research and development of medical countermeasures through agile and distributed drug substance and drug product manufacturing capacities. This includes establishing end-to-end manufacturing capacities under current good manufacturing practices (cGMP) and all associated regulatory filings to include drug master files (DMFs), New Drug Applications, (NDAs) and Abbreviated New Drug Applications (ANDAs). This scope also includes the use of qualified laboratories for product verification, environmental and shelf-life testing, and adherence to industry-recognized consensus standards applicable to performance and its goals (e.g., ISO, ASTM).
Details
RPP Amendment 3 Released: November 5, 2026
Proposals Due: November 9, 2026 by 5 PM ET
Changes: Reopens the RPP for proposal submissions and updates Section 3 and Attachment A of the RPP. If you have already submitted your proposal and do not wish to make any changes, you do not need to resubmit it. However, all submissions will remain available for editing until the submission deadline.
–
RPP Amendment 2 Released: October 16, 2026
Changes: Revises the cover page, Section 4, and Attachments A, B, and C of the RPP.
–
Q&A Released: October 16, 2026
–
RPP Amendment 1 Released: October 15, 2026
Proposals Due: November 2, 2026 by 1 PM ET
Changes: Extends the proposal submission due date from October 21, 2026 to November 2, 2026 by 1 PM ET.
–
RPP Released: September 21, 2026